Intervention

placebo/celecoxib 400 mg and cholecalciferol 400 IU/cholecalciferol 2,000 IU

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Changes in Biomarkers Using Prostaglandin InhibitorsNCT01769625 · 2009-01-01

COMPLETED

Common conditions

Biomarker Change Linked to Breast Cancer1

Leading sponsors

Hartford Hospital1

Trial status mix

COMPLETED1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.